Literature DB >> 3292210

Drug treatment of stroke. Current status and future prospects.

C A Sila1, A J Furlan.   

Abstract

Despite advances in the understanding of the mechanism of cerebral injury during focal ischaemia, the best treatment of cerebral ischaemia is still prevention. The pathophysiological mechanisms that contribute to cerebral ischaemia are discussed relative to the many therapeutic interventions that have been attempted. It is our impression that the treatment of such a complex multifactor process will require multimodal therapy, as most of the unifactorial therapies used to date have proven relatively unsuccessful in improving neurological outcome and survival.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3292210     DOI: 10.2165/00003495-198835040-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  83 in total

1.  Double-blind study of the effects of dexamethasone on acute stroke.

Authors:  B M Patten; J Mendell; B Bruun; W Curtin; S Carter
Journal:  Neurology       Date:  1972-04       Impact factor: 9.910

2.  The effect of intra-arterial papaverine on the regional cerebral blood flow in patients with stroke or intracranial tumor.

Authors:  J Olesen; O B Paulson
Journal:  Stroke       Date:  1971 Mar-Apr       Impact factor: 7.914

3.  Multicenter trial of hemodilution in ischemic stroke--background and study protocol. Scandinavian Stroke Study Group.

Authors: 
Journal:  Stroke       Date:  1985 Sep-Oct       Impact factor: 7.914

Review 4.  Diagnosis and management of ischemic stroke. Part II. Selected controversies.

Authors:  R G Hart; D G Sherman; V T Miller; J D Easton
Journal:  Curr Probl Cardiol       Date:  1983-10       Impact factor: 5.200

5.  Transport of oxygen to the brain in patients with elevated haematocrit values before and after venesection.

Authors:  J P Wade
Journal:  Brain       Date:  1983-06       Impact factor: 13.501

6.  Effects of calcium channel blockers on pial vascular responses to receptor mediated constrictors.

Authors:  W I Rosenblum
Journal:  Stroke       Date:  1984 Mar-Apr       Impact factor: 7.914

7.  A pilot study of urokinase therapy in cerebral infarction.

Authors:  A P Fletcher; N Alkjaersig; M Lewis; V Tulevski; A Davies; J E Brooks; W B Hardin; W M Landau; M E Raichle
Journal:  Stroke       Date:  1976 Mar-Apr       Impact factor: 7.914

8.  Baseline hemodynamic state and response to hemodilution in patients with acute cerebral ischemia.

Authors:  J C Grotta; L C Pettigrew; S Allen; A Tonnesen; F M Yatsu; J Gray; J Spydell
Journal:  Stroke       Date:  1985 Sep-Oct       Impact factor: 7.914

9.  Anticoagulation in cerebral ischemia.

Authors:  B B Weksler; M Lewin
Journal:  Stroke       Date:  1983 Sep-Oct       Impact factor: 7.914

10.  A dose-escalation study of large doses of naloxone for treatment of patients with acute cerebral ischemia.

Authors:  H P Adams; C P Olinger; W G Barsan; M J Butler; N R Graff-Radford; T G Brott; J Biller; H Damasio; T Tomsick; M Goldberg
Journal:  Stroke       Date:  1986 May-Jun       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.